Abstract
Sensitized patients awaiting heart transplantation (HTx) are known to have less optimal post-transplant outcome. Those patients at risk for sensitization include previous blood transfusions, pregnancy, and/or organ transplants. We sought to evaluate our pre-transplant patients, dividing them into naïve patients (those without sensitization) vs memory patients (those at risk for sensitization or with detected circulating antibodies) and comparing them for post-transplant outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
